Indication: Thrombolytic therapy

Dosage Form:Injection

Route of Administration:Intravenous Drip

Shelf Life:18 months

Storage:Sealed

Place of Origin:China

Qualification:Chinese GMP

Indication:PCOS, polycystic ovary syndrome

Specification:75IU (5.5μg)/ 1.0ml/ vial

Dosage Form:Injection

Route of Administration:Subcutaneous Injection

Shelf Life:18 months

Storage:2℃-8℃

Place of Origin:China

Qualification:Chinese GMP

CAS:NT-1

Indication:Vasodilatory to treat angina Dosage Form

Specification:5mg;

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Package:12 tablets per box, 200 boxes in a carton

Place of Origin:China Mainland

Qualification:Chinese GMP

Indication:100ml:0.6g:0.9g 250ml:0.2g:2.25g

Specification:Marine

Dosage Form:Injection

Route of Administration:Oral

Shelf Life:3 years

Storage:Sealed

Place of Origin:China

Qualification:Chinese GMP

CAS:0113427-24-0

Indication:1. Anemia resulting from renal function insufficiency, including hemodialysis and non-hemodialysis 2. Red blood cell mobilization during surgical perioperative period.

Specification:2000IU,3000IU,4000IU,6000IU,10000IU

Dosage Form:Injection

Active Ingredients:erythropoietin

Route of Administration:Subcutaneous Injection

Shelf Life:2 years

Storage:2℃-8℃

Package:1 vial/syringe

Place of Origin:China

Qualification:Chinese GMP

CAS:002

Indication:Noradrenaline(Norepinephrine)Injection

Specification:Noradrenaline(Norepinephrine)Injection

Dosage Form:Injection

Active Ingredients:Noradrenaline

Route of Administration:Intramuscular Injection

Shelf Life:3 years

Storage:Sealed

Package:10 x 4 ml

Qualification:EU GMP

Indication:Hypertension.

Specification:10mg/tablet

Dosage Form:Injection

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:Chinese GMP

Indication:Metoprolol succinate extended-release tablets are contraindicated in severe bradycardia, second or third degree heart block, cardiogenic shock, decompensated cardiac failure, sick sinus syndrome (unle

Specification:25mg,50mg,100mg,200mg

Dosage Form:Tablet

Active Ingredients:Metoprolol

Route of Administration:Oral

Shelf Life:2 years

Storage:Protected from light

Qualification:FDA

Indication:For the treatment of essential hypertension. For the treatment of patients whose blood pressure cannot be effectively controlled by using irbesartan or hydrochlorothiazide alone.

Specification:150 mg of irbesartan and 12.5 mg of hydrochlorothiazide

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:3 years

Storage:Sealed

Qualification:Chinese GMP

Indication: For the treatment of essential hypertension

Specification:Each tablet contains 20 mg of olmesartan medoxomil and 5 mg of amlodipine besylate

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:Chinese GMP

Indication:For the treatment of hypertension. Indicated in patients whose blood pressure is not adequately controlled with olmesartan medoxomil or hydrochlorothiazide alone.

Specification:Per Tablet Contains: Olmesartan medoxomil 20 mg and Hydrochlorothiazide 12.5 mg

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:Chinese GMP

Indication:Used for adult patients with hypertension whose blood pressure is inadequately controlled by monotherapy. Serves as an alternative therapy for patients with essential hypertension controlled by the c

Specification:Each tablet contains 10 mg of perindopril arginine and 5 mg of amlodipine besylate (calculated as C₂₀H₂₅ClN₂O₅).

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:Chinese GMP

Indication:For the treatment of hypercholesterolemia

Specification:10 mg

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:3 years

Storage:Sealed

Qualification:Chinese GMP

Indication:Treatment of essential hypertension.

Specification:Each tablet contains 80 mg of valsartan and 5 mg of amlodipine.

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:3 years

Storage:Sealed

Qualification:Chinese GMP

Indication: For treating mild to moderate essential hypertension when valsartan alone cannot adequately control blood pressure

Specification:80mg of valsartan potassium and 12.5mg of hydrochlorothiazide

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:Chinese GMP

Indication:1. Treatment of Microangiopathies; 2.Adjunctive Therapy for Chronic Venous Insufficiency (CVI)

Specification:0.5g

Dosage Form:Capsule

Route of Administration:Oral

Shelf Life:3 years

Storage:Sealed

Qualification:Chinese GMP

Indication:On the basis of diet control, this product is used to reduce the triglyceride (TG) levels in adult patients with severe hypertriglyceridemia (≥500 mg/dL). The impact of this product on the risk of pa

Specification:1g (containing ethyl eicosapentaenoate 465 mg, ethyl docosahexaenoate 375 mg, and total ω-3 fatty acid ethyl esters no less than 900 mg).

Dosage Form:Capsule

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:Chinese GMP

Indication:Ginkgolide injection indicated for the treatment of mild to moderate cerebral infarction.

Specification:2ml:10mg

Dosage Form:Injection

Active Ingredients:Ginkgolide A,B,C and bilobalide

Route of Administration:Intravenous Drip

Shelf Life:2 years

Storage:Sealed

Package:Unopened glass ampoules, 5 ampoules/box, 100 boxes/carton (Can be customized)

Place of Origin:China

Qualification:FDA

Specification:25mg

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:3 years

Storage:Sealed

Qualification:Chinese GMP

Specification:25000IU/5ml;50000IU/5ml.

Dosage Form:Injection

Route of Administration:Intravenous Drip

Shelf Life:18 months

Storage:Sealed

Qualification:Chinese GMP